Category: ICYMI Articles
Day 2 of the ACC 2016 Scientific Session and Expo in Chicago – watch as Abiomed’s VP of Interventional Cardiology Programs, Dr. Seth Bilazarian, discusses some highlights.
Today the ACC 2016 Scientific Session and Expo kicked off in Chicago. Watch as Abiomed’s VP of Interventional Cardiology Programs, Dr. Seth Bilazarian, discusses some Day 1 highlights.
On Friday, December 4, 2015, a course entitled “Building your Impella Program: Lessons from Greenville Health System” was presented to cardiac catheterization laboratory physicians, nurses and technicians in Greenville, South Carolina. Two physicians, Drs. Josh Doll and Jesse Jorgensen from the Greenville Health System, Greenville, SC, led the primary discussion around Protected PCI.Dr. Doll’s presentation, entitled “Updated Guidelines, Patient Identification and Clinical Data,” reviewed the rationale for hemodynamic support and the growing population of patients with a combination of complex coronary anatomy, reduced left ventricular function and comorbidities. These patients are often turned down for surgery and remain undertreated in community settings. As a result, these patients are often in emergency rooms repeatedly, and readmitted to the hospital, using health care resources at a high cost.Continue readingBuilding Your Impella Program: Lessons from Greenville Health System
Dr. Seth Bilazarian, Vice President of Interventional Cardiology Programs at Abiomed, attended TCT 2015 and blogged about what he learned in a recent blog post. The Protected PCI blogging team also called him on the event’s last day to learn more. Transcript: Benjamin: Hi, I’m Benjamin Hunting, and welcome to the Protected PCI Podcast. Today’s topic … Continue reading “Dr. Seth Bilazarian’s Top Takeaways from TCT 2015”
The first day of the Advanced Hemodynamic Course hosted by Abiomed was on Thursday, November 5, 2015 in Frankfurt, Germany. The course began with Protected PCI case presentations.Prof. Nikos Werner, MD from the University Hospital Bonn, Bonn, Germany presented the first case entitled “Elective Protected PCI.” Prof. Werner noted the patient undergoing elective PCI is usually in stable condition, which is different from patients experiencing an acute myocardial infarction or in shock. Prof. Werner described a 77 year old patient with angina CCS 3 and dyspnea NYHA III, an ejection fraction of 35% and chronic obstructive pulmonary disease. Current coronary issues are severe left main equivalent disease extending into the left anterior descending artery and diseased right coronary artery. The patient also had diabetes, hypertension, and hyperlipidemia.Previous cardiac history included coronary artery bypass graft surgery (CABG) 10 years earlier with left internal mammary artery and saphenous vein graft. The patient was referred for repeat CABG, which the heart team denied. High-risk PCI was suggested as an alternative.Continue readingProtected PCI Cases Highlight Day 1 of the 2015 EU Advanced Hemodynamic Course in Frankfurt
This year’s 26th annual 2015 Scripps Cardiovascular Interventions event will be held at the Hilton La Jolla Torrey Pines in La Jolla, California and will run from October 27-30. This event will demonstrate the latest advances in interventional cardiology through a “program of lectures from world experts, live demonstration procedures, and participant-faculty interactions." Continue readingScripps 2015 Preview: Protected PCI to be Highlighted at Pre-Conference Seminar
Use of Hemodynamic Support for High Risk PCI was clearly a major focus at TCT 2015 with multiple didactic sessions and multiple taped and live cases demonstrating its safe and effective useWhat I learned (or at least had reinforced)Continue readingHemodynamic Support for High-Risk PCI a Key Focus of TCT 2015